Atlas Trials

A Study for Participants With Metastatic Renal Cell Carcinoma

Clinical trial NCT00709995 · COMPLETED

Trial details

NCT number
NCT00709995
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cell Carcinoma
Start date
2008-06-30
Primary completion
2010-02-15
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.